VYMADA
LIVE

Serial Number

79225186

Owner

NOVARTIS AG

Filing Date

Nov 15, 2017

Add to watchlist:

No watchlists yet
View on USPTO

VYMADA Trademark

Serial Number: 79225186 • Registration: 5500064

VYMADA is a trademark filed by NOVARTIS AG on November 15, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 15, 2017

Registration Date

June 26, 2018

Published for Opposition

April 10, 2018

Cancellation Date

September 30, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION PROCESSED BY IB
Sep 11, 2022 GPNX
NOTIFICATION PROCESSED BY IB
Mar 13, 2022 GPNX
INTERNATIONAL REGISTRATION RENEWED
Feb 1, 2022 RNWL
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 3, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 3, 2021 DETH
NOTIFICATION PROCESSED BY IB
Sep 28, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 8, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 8, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 26, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 26, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 10, 2018 PUBO
NOTICE OF PUBLICATION
Mar 21, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2018 CNSA
ASSIGNED TO EXAMINER
Feb 26, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 26, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 19, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jan 18, 2018 SDRC